AI assistant
Novonesis AS Director's Dealing 2017
3377_rns_2017-08-24_04e87870-9d48-411e-acc2-98c98a576901.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Transaktioner af ledende medarbejdere samt disses nærtstående
I henhold til artikel 19 i EU forordning nr. 596/2014 af 16. april 2014 om markedsmisbrug (markedsmisbrugsforordningen) samt kommissionens forordning nr. 1052/2016 af 8. marts 2016 offentliggør Novozymes hermed følgende transaktioner under Fondskode (ISIN) DK0060336014, Novozymes B-aktier under betegnelsen NZYM B
Nærmere oplysninger om personen med ledelsesansvar/personen med nær tilknytning til denne
Navn
Peder Holk Nielsen
Årsag til indberetningen
| Stilling/titel | CEO |
|---|---|
| Første indberetning/ændring | Første indberetning |
Nærmere oplysninger om udstederen
| Enhed | Novozymes A/S |
|---|---|
| LEI-kode | 529900T6WNZXD2R3JW38 |
Nærmere oplysninger om transaktionen/transaktionerne
| Beskrivelse: | |
|---|---|
| Det finansielle instrument | Aktier |
| Identifikationskode | ISIN DK0060336014 |
| Transaktionens art | Køb af aktier fra udnyttelse af aktieoptioner |
| Sted for transaktion(er), pris(er) og mængde(r) | Novozymes eget depot |
| Købspris, DKK: 88,6 | |
| Antal aktier: 121.215 | |
| Transaktionsværdi, DKK: 10.739.649 | |
| Aggregerede oplysninger | Antal aktier: 121.215 |
| Transaktionsværdi, DKK: 10.739.649 | |
| Dato for transaktionen | 2017-08-23 |
- august, 2017
Selskabsmeddelelse nr. 59
Kontaktinformation
Tobias Cornelius Björklund
+45 3077 8682
[email protected]
Klaus Sindahl
+45 5363 0134
[email protected]
Om Novozymes
Novozymes er verdens førende inden for biologiske løsninger. Sammen med kunder, partnere og det globale samfund forbedrer vi industriel produktion og bidrager til at bevare naturens ressourcer og skabe bedre levevilkår. Vi er verdens største leverandør af enzymer og mikrobiel teknologi. Med vores bioinnovation kan vi eksempelvis muliggøre højere høstudbytter i landbruget, tøjvask ved lavere temperaturer, energibesparelser i fremstillingsprocesser, fornybare brændstoffer og mange andre fremskridt, som vi har brug for både i dag og i fremtiden. Vi kalder det Rethink Tomorrow. www.novozymes.com
Novozymes A/S CVR nummer: 10-90 71 27
LEI: 529900T6WNZXD2R3JW38
Netvokselsforeningen
Novozymes A/S
Krogshøjvej 36
2880 Bagsværd
Danmark
Telefon: +45 4446 0000
Rethink Tomorrow
novozymes
Selskabsmeddelelse nr. 59
2/18
Nærmere oplysninger om personen med ledelsesansvar/personen med nær tilknytning til denne
| Navn | Peder Holk Nielsen |
|---|---|
| Årsag til indberetningen | |
| Stilling/titel | CEO |
| Første indberetning/ændring | Første indberetning |
| Nærmere oplysninger om udstederen | |
| Enhed | Novozymes A/S |
| LEI-kode | 529900T6WNZXD2R3JW38 |
| Nærmere oplysninger om transaktionen/transaktionerne | |
| Beskrivelse: | |
| Det finansielle instrument | Aktier |
| Identifikationskode | ISIN DK0060336014 |
| Transaktionens art | Salg af aktier |
| Sted for transaktion(er), pris(er) og mængde(r) | XCSE |
| Se Bilag 1 for detaljerede oplysninger | |
| Aggregerede oplysninger | Antal aktier: 10.000 |
| Gennemsnitspris, DKK: 311 | |
| Transaktionsværdi, DKK: 3.106.112 | |
| Dato for transaktionen | 2017-08-23 |
Nærmere oplysninger om personen med ledelsesansvar/personen med nær tilknytning til denne
| Navn | Peder Holk Nielsen |
|---|---|
| Årsag til indberetningen | |
| Stilling/titel | CEO |
| Første indberetning/ændring | Første indberetning |
| Nærmere oplysninger om udstederen | |
| Enhed | Novozymes A/S |
| LEI-kode | 529900T6WNZXD2R3JW38 |
| Nærmere oplysninger om transaktionen/transaktionerne | |
| Beskrivelse: | |
| Det finansielle instrument | Aktier |
| Identifikationskode | ISIN DK0060336014 |
| Transaktionens art | Salg af aktier |
| Sted for transaktion(er), pris(er) og mængde(r) | XCSE |
| Se Bilag 2 for detaljerede oplysninger | |
| Aggregerede oplysninger | Antal aktier: 29.000 |
| Gennemsnitspris, DKK: 313 | |
| Transaktionsværdi, DKK: 9.079.758 | |
| Dato for transaktionen | 2017-08-24 |
Rethink Tomorrow
novozymes
Selskabsmeddelelse nr. 59
3/18
Bilag 1
| Volume | Price | Time |
|---|---|---|
| 9 | 311.3 | 23-08-2017 15:55 |
| 27 | 310.9 | 23-08-2017 15:58 |
| 14 | 310.9 | 23-08-2017 15:58 |
| 139 | 310.9 | 23-08-2017 15:58 |
| 52 | 310.9 | 23-08-2017 15:58 |
| 51 | 310.9 | 23-08-2017 15:58 |
| 152 | 311 | 23-08-2017 15:58 |
| 120 | 311 | 23-08-2017 15:58 |
| 141 | 311 | 23-08-2017 15:58 |
| 70 | 311 | 23-08-2017 15:58 |
| 5 | 311 | 23-08-2017 15:58 |
| 86 | 311.3 | 23-08-2017 16:00 |
| 14 | 311.2 | 23-08-2017 16:00 |
| 57 | 311.2 | 23-08-2017 16:00 |
| 38 | 311.2 | 23-08-2017 16:00 |
| 44 | 311.2 | 23-08-2017 16:00 |
| 1 | 311.2 | 23-08-2017 16:00 |
| 26 | 311.3 | 23-08-2017 16:03 |
| 4 | 311.3 | 23-08-2017 16:03 |
| 21 | 311.3 | 23-08-2017 16:03 |
| 8 | 311.3 | 23-08-2017 16:03 |
| 11 | 311.3 | 23-08-2017 16:03 |
| 32 | 311.3 | 23-08-2017 16:03 |
| 35 | 311.5 | 23-08-2017 16:03 |
| 28 | 311.5 | 23-08-2017 16:03 |
| 25 | 311.5 | 23-08-2017 16:03 |
| 13 | 311.5 | 23-08-2017 16:03 |
| 33 | 311.6 | 23-08-2017 16:05 |
| 34 | 311.6 | 23-08-2017 16:05 |
| 16 | 311.6 | 23-08-2017 16:05 |
| 22 | 311.6 | 23-08-2017 16:05 |
| 25 | 311.6 | 23-08-2017 16:09 |
| 66 | 311.6 | 23-08-2017 16:10 |
| 59 | 311.6 | 23-08-2017 16:10 |
| 56 | 311.6 | 23-08-2017 16:10 |
| 48 | 311.6 | 23-08-2017 16:13 |
| 31 | 311.6 | 23-08-2017 16:13 |
| 100 | 311.6 | 23-08-2017 16:13 |
| 140 | 311.45 | 23-08-2017 16:16 |
| 179 | 311.25 | 23-08-2017 16:18 |
| 66 | 311.2 | 23-08-2017 16:20 |
| 78 | 311.2 | 23-08-2017 16:21 |
Rethink Tomorrow
novozymes
Selskabsmeddelelse nr. 59
4/18
| 65 | 311.2 | 23-08-2017 16:21 |
|---|---|---|
| 26 | 311.2 | 23-08-2017 16:21 |
| 16 | 311.2 | 23-08-2017 16:21 |
| 45 | 311.2 | 23-08-2017 16:21 |
| 26 | 311.3 | 23-08-2017 16:22 |
| 141 | 310.95 | 23-08-2017 16:25 |
| 93 | 311 | 23-08-2017 16:25 |
| 62 | 311 | 23-08-2017 16:25 |
| 38 | 311 | 23-08-2017 16:25 |
| 33 | 311 | 23-08-2017 16:25 |
| 23 | 311 | 23-08-2017 16:25 |
| 41 | 311 | 23-08-2017 16:25 |
| 2 | 311 | 23-08-2017 16:25 |
| 111 | 310.8 | 23-08-2017 16:31 |
| 87 | 310.4 | 23-08-2017 16:33 |
| 141 | 310.4 | 23-08-2017 16:33 |
| 60 | 310.4 | 23-08-2017 16:33 |
| 32 | 310.35 | 23-08-2017 16:34 |
| 213 | 310.45 | 23-08-2017 16:34 |
| 142 | 310.45 | 23-08-2017 16:36 |
| 14 | 310.5 | 23-08-2017 16:36 |
| 24 | 310.4 | 23-08-2017 16:37 |
| 38 | 310.4 | 23-08-2017 16:37 |
| 46 | 310.4 | 23-08-2017 16:37 |
| 35 | 310.4 | 23-08-2017 16:37 |
| 45 | 310.5 | 23-08-2017 16:39 |
| 23 | 310.5 | 23-08-2017 16:39 |
| 15 | 310.5 | 23-08-2017 16:39 |
| 36 | 310.5 | 23-08-2017 16:39 |
| 29 | 310.8 | 23-08-2017 16:42 |
| 98 | 310.6 | 23-08-2017 16:45 |
| 171 | 310.6 | 23-08-2017 16:45 |
| 18 | 310.6 | 23-08-2017 16:45 |
| 35 | 310.7 | 23-08-2017 16:46 |
| 5 | 310.7 | 23-08-2017 16:46 |
| 56 | 310.7 | 23-08-2017 16:46 |
| 21 | 310.7 | 23-08-2017 16:46 |
| 60 | 310.7 | 23-08-2017 16:46 |
| 3 | 310.7 | 23-08-2017 16:46 |
| 28 | 310.9 | 23-08-2017 16:47 |
| 33 | 310.9 | 23-08-2017 16:47 |
| 17 | 310.9 | 23-08-2017 16:47 |
| 21 | 310.9 | 23-08-2017 16:47 |
| 23 | 310.8 | 23-08-2017 16:50 |
| 59 | 310.6 | 23-08-2017 16:51 |
| 80 | 310.6 | 23-08-2017 16:51 |
Rethink Tomorrow
novozymes
Selskabsmeddelelse nr. 59
5/18
| 42 | 310.6 | 23-08-2017 16:51 |
|---|---|---|
| 70 | 310.6 | 23-08-2017 16:51 |
| 44 | 310.6 | 23-08-2017 16:51 |
| 32 | 310.6 | 23-08-2017 16:53 |
| 13 | 310.6 | 23-08-2017 16:53 |
| 15 | 310.6 | 23-08-2017 16:53 |
| 15 | 310.6 | 23-08-2017 16:53 |
| 31 | 310.6 | 23-08-2017 16:53 |
| 63 | 310.6 | 23-08-2017 16:54 |
| 69 | 310.6 | 23-08-2017 16:54 |
| 12 | 310.6 | 23-08-2017 16:54 |
| 4,786 | 310.3 | 23-08-2017 16:59 |
| 202 | 310.3 | 23-08-2017 16:59 |
Rethink Tomorrow
novozymes
Selskabsmeddelelse nr. 59
6/18
Bilag 2
| Volume | Price | Time |
|---|---|---|
| 71 | 311.1 | 24-08-2017 09:15 |
| 17 | 311.1 | 24-08-2017 09:15 |
| 21 | 311.1 | 24-08-2017 09:15 |
| 71 | 311.1 | 24-08-2017 09:15 |
| 13 | 311.1 | 24-08-2017 09:15 |
| 11 | 311.1 | 24-08-2017 09:15 |
| 127 | 311.2 | 24-08-2017 09:16 |
| 54 | 311.2 | 24-08-2017 09:16 |
| 84 | 311.2 | 24-08-2017 09:16 |
| 36 | 311.2 | 24-08-2017 09:16 |
| 24 | 311.2 | 24-08-2017 09:16 |
| 8 | 311.2 | 24-08-2017 09:16 |
| 31 | 311 | 24-08-2017 09:20 |
| 19 | 311 | 24-08-2017 09:20 |
| 31 | 311 | 24-08-2017 09:20 |
| 45 | 311 | 24-08-2017 09:20 |
| 16 | 311 | 24-08-2017 09:20 |
| 149 | 311 | 24-08-2017 09:20 |
| 31 | 311 | 24-08-2017 09:20 |
| 31 | 311 | 24-08-2017 09:20 |
| 3 | 311 | 24-08-2017 09:20 |
| 16 | 311 | 24-08-2017 09:20 |
| 14 | 311 | 24-08-2017 09:20 |
| 17 | 311 | 24-08-2017 09:20 |
| 38 | 311 | 24-08-2017 09:20 |
| 31 | 311 | 24-08-2017 09:20 |
| 18 | 311.1 | 24-08-2017 09:24 |
| 48 | 311.1 | 24-08-2017 09:24 |
| 161 | 311.1 | 24-08-2017 09:24 |
| 48 | 311.1 | 24-08-2017 09:24 |
| 75 | 311.1 | 24-08-2017 09:24 |
| 43 | 311.1 | 24-08-2017 09:24 |
| 22 | 311.1 | 24-08-2017 09:24 |
| 46 | 311.2 | 24-08-2017 09:25 |
| 19 | 311.2 | 24-08-2017 09:25 |
| 23 | 311.2 | 24-08-2017 09:25 |
| 49 | 311.2 | 24-08-2017 09:25 |
| 71 | 311.2 | 24-08-2017 09:27 |
| 29 | 311.2 | 24-08-2017 09:27 |
| 43 | 311.2 | 24-08-2017 09:27 |
| 4 | 311.2 | 24-08-2017 09:27 |
| 20 | 311.2 | 24-08-2017 09:27 |
| 27 | 311.5 | 24-08-2017 09:30 |
Rethink Tomorrow
novozymes
Selskabsmeddelelse nr. 59
7/18
| 16 | 311.5 | 24-08-2017 09:30 |
|---|---|---|
| 36 | 311.5 | 24-08-2017 09:30 |
| 13 | 311.5 | 24-08-2017 09:30 |
| 78 | 311.6 | 24-08-2017 09:30 |
| 57 | 311.6 | 24-08-2017 09:30 |
| 13 | 311.6 | 24-08-2017 09:30 |
| 14 | 311.4 | 24-08-2017 09:31 |
| 40 | 311.4 | 24-08-2017 09:31 |
| 72 | 311.4 | 24-08-2017 09:31 |
| 21 | 311.4 | 24-08-2017 09:31 |
| 54 | 311.4 | 24-08-2017 09:33 |
| 28 | 311.4 | 24-08-2017 09:33 |
| 7 | 311.4 | 24-08-2017 09:33 |
| 13 | 311.5 | 24-08-2017 09:35 |
| 19 | 311.5 | 24-08-2017 09:35 |
| 68 | 311.5 | 24-08-2017 09:35 |
| 12 | 311.5 | 24-08-2017 09:35 |
| 2 | 311.5 | 24-08-2017 09:35 |
| 10 | 311.5 | 24-08-2017 09:35 |
| 19 | 311.5 | 24-08-2017 09:35 |
| 72 | 311.3 | 24-08-2017 09:40 |
| 59 | 311.3 | 24-08-2017 09:40 |
| 48 | 311.3 | 24-08-2017 09:40 |
| 105 | 311.3 | 24-08-2017 09:40 |
| 105 | 311.3 | 24-08-2017 09:40 |
| 11 | 311.3 | 24-08-2017 09:40 |
| 4,285 | 311.8294 | 24-08-2017 11:08 |
| 131 | 313.8 | 24-08-2017 11:08 |
| 48 | 313.8 | 24-08-2017 11:08 |
| 150 | 313.8 | 24-08-2017 11:08 |
| 157 | 313.8 | 24-08-2017 11:08 |
| 62 | 313.8 | 24-08-2017 11:08 |
| 17 | 313.8 | 24-08-2017 11:08 |
| 63 | 313.6 | 24-08-2017 11:09 |
| 109 | 313.6 | 24-08-2017 11:09 |
| 24 | 313.6 | 24-08-2017 11:09 |
| 28 | 313.6 | 24-08-2017 11:09 |
| 24 | 313.6 | 24-08-2017 11:09 |
| 20 | 313.6 | 24-08-2017 11:16 |
| 53 | 313.6 | 24-08-2017 11:16 |
| 17 | 313.6 | 24-08-2017 11:16 |
| 81 | 313.6 | 24-08-2017 11:16 |
| 67 | 313.5 | 24-08-2017 11:17 |
| 68 | 313.5 | 24-08-2017 11:17 |
| 20 | 313.5 | 24-08-2017 11:17 |
| 10 | 313.5 | 24-08-2017 11:17 |
Rethink Tomorrow
novozymes
Selskabsmeddelelse nr. 59
8/18
| 67 | 313.5 | 24-08-2017 11:17 |
|---|---|---|
| 20 | 313.5 | 24-08-2017 11:17 |
| 67 | 313.5 | 24-08-2017 11:18 |
| 29 | 313.5 | 24-08-2017 11:18 |
| 10 | 313.5 | 24-08-2017 11:18 |
| 10 | 313.5 | 24-08-2017 11:18 |
| 65 | 313.6 | 24-08-2017 11:20 |
| 35 | 313.6 | 24-08-2017 11:20 |
| 69 | 313.6 | 24-08-2017 11:20 |
| 49 | 313.6 | 24-08-2017 11:21 |
| 26 | 313.6 | 24-08-2017 11:23 |
| 17 | 313.6 | 24-08-2017 11:23 |
| 37 | 313.6 | 24-08-2017 11:23 |
| 16 | 313.6 | 24-08-2017 11:23 |
| 17 | 313.7 | 24-08-2017 11:24 |
| 68 | 313.7 | 24-08-2017 11:26 |
| 17 | 313.7 | 24-08-2017 11:27 |
| 10 | 313.7 | 24-08-2017 11:27 |
| 45 | 313.7 | 24-08-2017 11:27 |
| 59 | 313.5 | 24-08-2017 11:32 |
| 74 | 313.5 | 24-08-2017 11:32 |
| 2 | 313.5 | 24-08-2017 11:32 |
| 71 | 313.5 | 24-08-2017 11:32 |
| 68 | 313.5 | 24-08-2017 11:32 |
| 2 | 313.5 | 24-08-2017 11:32 |
| 118 | 313.5 | 24-08-2017 11:32 |
| 71 | 313.5 | 24-08-2017 11:32 |
| 43 | 313.5 | 24-08-2017 11:32 |
| 27 | 313.6 | 24-08-2017 11:33 |
| 12 | 313.5 | 24-08-2017 11:35 |
| 18 | 313.5 | 24-08-2017 11:35 |
| 55 | 313.5 | 24-08-2017 11:35 |
| 17 | 313.5 | 24-08-2017 11:35 |
| 7 | 313.6 | 24-08-2017 11:37 |
| 38 | 313.6 | 24-08-2017 11:37 |
| 17 | 313.6 | 24-08-2017 11:37 |
| 17 | 313.6 | 24-08-2017 11:37 |
| 20 | 313.6 | 24-08-2017 11:37 |
| 88 | 313.8 | 24-08-2017 11:39 |
| 88 | 313.8 | 24-08-2017 11:39 |
| 40 | 313.8 | 24-08-2017 11:39 |
| 27 | 313.8 | 24-08-2017 11:39 |
| 11 | 313.8 | 24-08-2017 11:39 |
| 59 | 313.8 | 24-08-2017 11:39 |
| 26 | 313.8 | 24-08-2017 11:39 |
| 88 | 313.8 | 24-08-2017 11:39 |
Rethink Tomorrow
novozymes
Selskabsmeddelelse nr. 59
9/18
| 128 | 313.8 | 24-08-2017 11:39 |
|---|---|---|
| 88 | 313.8 | 24-08-2017 11:39 |
| 144 | 313.8 | 24-08-2017 11:39 |
| 88 | 313.8 | 24-08-2017 11:39 |
| 124 | 313.8 | 24-08-2017 11:39 |
| 27 | 313.8 | 24-08-2017 11:39 |
| 16 | 313.8 | 24-08-2017 11:39 |
| 29 | 313.8 | 24-08-2017 11:39 |
| 17 | 313.8 | 24-08-2017 11:39 |
| 88 | 313.8 | 24-08-2017 11:39 |
| 83 | 313.8 | 24-08-2017 11:39 |
| 42 | 313.8 | 24-08-2017 11:39 |
| 88 | 313.8 | 24-08-2017 11:39 |
| 58 | 313.8 | 24-08-2017 11:39 |
| 75 | 313.8 | 24-08-2017 11:39 |
| 13 | 313.8 | 24-08-2017 11:39 |
| 43 | 314 | 24-08-2017 11:42 |
| 20 | 314 | 24-08-2017 11:42 |
| 32 | 314 | 24-08-2017 11:42 |
| 19 | 314 | 24-08-2017 11:42 |
| 27 | 314.2 | 24-08-2017 11:43 |
| 107 | 314.2 | 24-08-2017 11:43 |
| 64 | 314.2 | 24-08-2017 11:43 |
| 42 | 314.2 | 24-08-2017 11:43 |
| 11 | 314.2 | 24-08-2017 11:44 |
| 13 | 314.2 | 24-08-2017 11:44 |
| 21 | 314.2 | 24-08-2017 11:44 |
| 12 | 314.2 | 24-08-2017 11:44 |
| 7 | 314.2 | 24-08-2017 11:44 |
| 43 | 314.2 | 24-08-2017 11:44 |
| 7 | 314.2 | 24-08-2017 11:44 |
| 47 | 314.1 | 24-08-2017 11:46 |
| 17 | 314.1 | 24-08-2017 11:46 |
| 31 | 314.1 | 24-08-2017 11:46 |
| 20 | 314.3 | 24-08-2017 11:47 |
| 43 | 314.3 | 24-08-2017 11:47 |
| 19 | 314.3 | 24-08-2017 11:47 |
| 2 | 314.4 | 24-08-2017 11:49 |
| 26 | 314.4 | 24-08-2017 11:49 |
| 19 | 314.4 | 24-08-2017 11:49 |
| 8 | 314.4 | 24-08-2017 11:49 |
| 22 | 314.4 | 24-08-2017 11:49 |
| 14 | 314.4 | 24-08-2017 11:49 |
| 35 | 314.4 | 24-08-2017 11:49 |
| 16 | 314.6 | 24-08-2017 11:50 |
| 27 | 314.6 | 24-08-2017 11:50 |
Rethink Tomorrow
novozymes
Selskabsmeddelelse nr. 59
10/18
| 17 | 314.6 | 24-08-2017 11:50 |
|---|---|---|
| 35 | 314.6 | 24-08-2017 11:50 |
| 40 | 314.7 | 24-08-2017 11:52 |
| 20 | 314.7 | 24-08-2017 11:52 |
| 35 | 314.7 | 24-08-2017 11:52 |
| 19 | 314.7 | 24-08-2017 11:52 |
| 19 | 314.9 | 24-08-2017 11:53 |
| 29 | 314.9 | 24-08-2017 11:53 |
| 20 | 314.9 | 24-08-2017 11:53 |
| 46 | 314.9 | 24-08-2017 11:53 |
| 41 | 314.9 | 24-08-2017 11:54 |
| 17 | 314.9 | 24-08-2017 11:54 |
| 21 | 314.9 | 24-08-2017 11:54 |
| 16 | 314.9 | 24-08-2017 11:54 |
| 35 | 314.8 | 24-08-2017 11:59 |
| 2 | 314.8 | 24-08-2017 11:59 |
| 37 | 314.8 | 24-08-2017 11:59 |
| 16 | 314.8 | 24-08-2017 11:59 |
| 16 | 314.8 | 24-08-2017 11:59 |
| 191 | 314.4 | 24-08-2017 12:02 |
| 54 | 314.4 | 24-08-2017 12:02 |
| 81 | 314.4 | 24-08-2017 12:02 |
| 49 | 314.4 | 24-08-2017 12:02 |
| 6 | 314.4 | 24-08-2017 12:02 |
| 36 | 314.5 | 24-08-2017 12:05 |
| 18 | 314.5 | 24-08-2017 12:05 |
| 34 | 314.5 | 24-08-2017 12:05 |
| 18 | 314.5 | 24-08-2017 12:05 |
| 26 | 314.2 | 24-08-2017 12:06 |
| 38 | 314.2 | 24-08-2017 12:06 |
| 11 | 314.2 | 24-08-2017 12:06 |
| 48 | 314.2 | 24-08-2017 12:06 |
| 29 | 314.2 | 24-08-2017 12:06 |
| 45 | 314 | 24-08-2017 12:10 |
| 18 | 314 | 24-08-2017 12:10 |
| 13 | 314 | 24-08-2017 12:10 |
| 31 | 314 | 24-08-2017 12:10 |
| 28 | 313.9 | 24-08-2017 12:12 |
| 48 | 313.9 | 24-08-2017 12:12 |
| 17 | 313.9 | 24-08-2017 12:12 |
| 38 | 313.9 | 24-08-2017 12:13 |
| 17 | 313.9 | 24-08-2017 12:13 |
| 30 | 313.9 | 24-08-2017 12:17 |
| 27 | 313.9 | 24-08-2017 12:18 |
| 30 | 313.9 | 24-08-2017 12:18 |
| 54 | 313.9 | 24-08-2017 12:18 |
Rethink Tomorrow
novozymes
Selskabsmeddelelse nr. 59
11/18
| 18 | 313.9 | 24-08-2017 12:18 |
|---|---|---|
| 18 | 313.9 | 24-08-2017 12:18 |
| 13 | 313.9 | 24-08-2017 12:18 |
| 67 | 314 | 24-08-2017 12:21 |
| 69 | 314 | 24-08-2017 12:21 |
| 84 | 314 | 24-08-2017 12:21 |
| 82 | 314 | 24-08-2017 12:21 |
| 98 | 314 | 24-08-2017 12:21 |
| 35 | 313.9 | 24-08-2017 12:21 |
| 41 | 313.9 | 24-08-2017 12:21 |
| 7 | 313.9 | 24-08-2017 12:21 |
| 27 | 313.9 | 24-08-2017 12:21 |
| 29 | 313.9 | 24-08-2017 12:21 |
| 46 | 313.9 | 24-08-2017 12:21 |
| 24 | 313.9 | 24-08-2017 12:21 |
| 47 | 313.8 | 24-08-2017 12:25 |
| 11 | 313.8 | 24-08-2017 12:25 |
| 36 | 313.8 | 24-08-2017 12:25 |
| 40 | 313.1 | 24-08-2017 12:29 |
| 31 | 313.1 | 24-08-2017 12:29 |
| 55 | 313.1 | 24-08-2017 12:29 |
| 30 | 313.1 | 24-08-2017 12:29 |
| 18 | 313.1 | 24-08-2017 12:29 |
| 19 | 313.2 | 24-08-2017 12:30 |
| 44 | 313.2 | 24-08-2017 12:30 |
| 20 | 313.2 | 24-08-2017 12:30 |
| 8 | 313.2 | 24-08-2017 12:30 |
| 31 | 313.2 | 24-08-2017 12:30 |
| 31 | 313.2 | 24-08-2017 12:34 |
| 30 | 313.2 | 24-08-2017 12:34 |
| 19 | 313.2 | 24-08-2017 12:34 |
| 27 | 313.2 | 24-08-2017 12:35 |
| 71 | 313.2 | 24-08-2017 12:35 |
| 6 | 313.2 | 24-08-2017 12:35 |
| 35 | 313.2 | 24-08-2017 12:35 |
| 20 | 313.2 | 24-08-2017 12:35 |
| 54 | 313.2 | 24-08-2017 12:35 |
| 17 | 313.2 | 24-08-2017 12:35 |
| 71 | 313.2 | 24-08-2017 12:35 |
| 70 | 313.2 | 24-08-2017 12:35 |
| 29 | 313.1 | 24-08-2017 12:37 |
| 23 | 313.1 | 24-08-2017 12:37 |
| 13 | 313.1 | 24-08-2017 12:37 |
| 35 | 313.1 | 24-08-2017 12:37 |
| 6 | 313.1 | 24-08-2017 12:37 |
| 36 | 313.3 | 24-08-2017 12:39 |
Rethink Tomorrow
novozymes
Selskabsmeddelelse nr. 59
12/18
| 21 | 313.3 | 24-08-2017 12:39 |
|---|---|---|
| 13 | 313.3 | 24-08-2017 12:39 |
| 33 | 313.3 | 24-08-2017 12:39 |
| 37 | 313.5 | 24-08-2017 12:43 |
| 31 | 313.5 | 24-08-2017 12:43 |
| 21 | 313.5 | 24-08-2017 12:43 |
| 14 | 313.5 | 24-08-2017 12:43 |
| 106 | 313.5 | 24-08-2017 12:50 |
| 52 | 313.5 | 24-08-2017 12:50 |
| 66 | 313.5 | 24-08-2017 12:50 |
| 99 | 313.5 | 24-08-2017 12:50 |
| 38 | 313.1 | 24-08-2017 12:52 |
| 17 | 313.1 | 24-08-2017 12:52 |
| 25 | 313.1 | 24-08-2017 12:52 |
| 10 | 313.1 | 24-08-2017 12:52 |
| 116 | 313.1 | 24-08-2017 12:52 |
| 4 | 313.1 | 24-08-2017 12:52 |
| 2 | 313.1 | 24-08-2017 12:52 |
| 21 | 313.1 | 24-08-2017 12:52 |
| 38 | 313.1 | 24-08-2017 12:52 |
| 25 | 313.1 | 24-08-2017 12:52 |
| 39 | 313.2 | 24-08-2017 12:55 |
| 17 | 313.2 | 24-08-2017 12:55 |
| 25 | 313.2 | 24-08-2017 12:55 |
| 26 | 313.2 | 24-08-2017 12:55 |
| 43 | 313.2 | 24-08-2017 12:57 |
| 73 | 313.2 | 24-08-2017 12:57 |
| 59 | 313.2 | 24-08-2017 12:57 |
| 98 | 313.2 | 24-08-2017 12:57 |
| 87 | 313.2 | 24-08-2017 12:58 |
| 59 | 313.2 | 24-08-2017 12:58 |
| 39 | 313.2 | 24-08-2017 12:58 |
| 93 | 313.2 | 24-08-2017 12:58 |
| 49 | 313.2 | 24-08-2017 12:58 |
| 12 | 313.2 | 24-08-2017 12:58 |
| 130 | 313.2 | 24-08-2017 12:58 |
| 15 | 313.3 | 24-08-2017 12:58 |
| 41 | 313.3 | 24-08-2017 12:58 |
| 28 | 313.3 | 24-08-2017 12:58 |
| 38 | 313.3 | 24-08-2017 12:58 |
| 11 | 313.3 | 24-08-2017 12:58 |
| 35 | 313.5 | 24-08-2017 13:05 |
| 16 | 313.5 | 24-08-2017 13:05 |
| 23 | 313.5 | 24-08-2017 13:05 |
| 54 | 313.5 | 24-08-2017 13:05 |
| 35 | 313.5 | 24-08-2017 13:05 |
Rethink Tomorrow
novozymes
Selskabsmeddelelse nr. 59
13/18
| 35 | 313.5 | 24-08-2017 13:05 |
|---|---|---|
| 35 | 313.5 | 24-08-2017 13:05 |
| 23 | 313.5 | 24-08-2017 13:05 |
| 12 | 313.5 | 24-08-2017 13:05 |
| 19 | 313.5 | 24-08-2017 13:05 |
| 24 | 313.5 | 24-08-2017 13:06 |
| 43 | 313.5 | 24-08-2017 13:06 |
| 27 | 313.5 | 24-08-2017 13:06 |
| 4 | 313.5 | 24-08-2017 13:06 |
| 41 | 313.5 | 24-08-2017 13:06 |
| 2 | 313.5 | 24-08-2017 13:06 |
| 115 | 313.1 | 24-08-2017 13:26 |
| 12 | 313.1 | 24-08-2017 13:26 |
| 246 | 313.1 | 24-08-2017 13:26 |
| 12 | 313.1 | 24-08-2017 13:26 |
| 114 | 313.1 | 24-08-2017 13:26 |
| 25 | 313.1 | 24-08-2017 13:26 |
| 284 | 313.1 | 24-08-2017 13:26 |
| 114 | 313.1 | 24-08-2017 13:26 |
| 21 | 313.1 | 24-08-2017 13:26 |
| 15 | 313.1 | 24-08-2017 13:26 |
| 56 | 313.1 | 24-08-2017 13:26 |
| 21 | 313.1 | 24-08-2017 13:26 |
| 24 | 313.1 | 24-08-2017 13:26 |
| 38 | 313.1 | 24-08-2017 13:26 |
| 13 | 313.1 | 24-08-2017 13:26 |
| 25 | 313.1 | 24-08-2017 13:26 |
| 25 | 313.1 | 24-08-2017 13:26 |
| 38 | 313.1 | 24-08-2017 13:26 |
| 16 | 313.1 | 24-08-2017 13:26 |
| 25 | 313.1 | 24-08-2017 13:26 |
| 6 | 313.1 | 24-08-2017 13:26 |
| 44 | 313.1 | 24-08-2017 13:26 |
| 24 | 313.1 | 24-08-2017 13:28 |
| 22 | 313.1 | 24-08-2017 13:28 |
| 15 | 313.1 | 24-08-2017 13:28 |
| 35 | 313.1 | 24-08-2017 13:28 |
| 37 | 313.6 | 24-08-2017 13:34 |
| 36 | 313.6 | 24-08-2017 13:34 |
| 16 | 313.6 | 24-08-2017 13:34 |
| 22 | 313.6 | 24-08-2017 13:35 |
| 62 | 313.7 | 24-08-2017 13:35 |
| 27 | 313.7 | 24-08-2017 13:36 |
| 17 | 313.7 | 24-08-2017 13:36 |
| 62 | 313.7 | 24-08-2017 13:36 |
| 62 | 313.7 | 24-08-2017 13:36 |
Rethink Tomorrow
novozymes
Selskabsmeddelelse nr. 59
14/18
| 56 | 313.7 | 24-08-2017 13:36 |
|---|---|---|
| 62 | 313.7 | 24-08-2017 13:36 |
| 78 | 313.6 | 24-08-2017 13:42 |
| 34 | 313.6 | 24-08-2017 13:42 |
| 34 | 313.6 | 24-08-2017 13:42 |
| 21 | 313.6 | 24-08-2017 13:42 |
| 41 | 313.6 | 24-08-2017 13:42 |
| 61 | 313.4 | 24-08-2017 13:51 |
| 252 | 313.4 | 24-08-2017 13:51 |
| 3 | 313.4 | 24-08-2017 13:51 |
| 58 | 313.4 | 24-08-2017 13:51 |
| 43 | 313.4 | 24-08-2017 13:51 |
| 34 | 313.4 | 24-08-2017 13:51 |
| 28 | 313.4 | 24-08-2017 13:51 |
| 16 | 313.4 | 24-08-2017 13:51 |
| 58 | 313.2 | 24-08-2017 13:57 |
| 49 | 313.2 | 24-08-2017 13:57 |
| 32 | 313.2 | 24-08-2017 13:57 |
| 15 | 313.2 | 24-08-2017 13:57 |
| 127 | 313.2 | 24-08-2017 14:02 |
| 63 | 313.2 | 24-08-2017 14:02 |
| 125 | 313.2 | 24-08-2017 14:02 |
| 35 | 313.2 | 24-08-2017 14:02 |
| 19 | 313.2 | 24-08-2017 14:02 |
| 39 | 313.3 | 24-08-2017 14:06 |
| 27 | 313.2 | 24-08-2017 14:10 |
| 55 | 313.2 | 24-08-2017 14:10 |
| 65 | 313.2 | 24-08-2017 14:10 |
| 86 | 313.2 | 24-08-2017 14:10 |
| 47 | 313.2 | 24-08-2017 14:10 |
| 22 | 313.2 | 24-08-2017 14:15 |
| 5 | 313.2 | 24-08-2017 14:17 |
| 50 | 313.2 | 24-08-2017 14:17 |
| 19 | 313.2 | 24-08-2017 14:17 |
| 49 | 313.2 | 24-08-2017 14:17 |
| 36 | 313.3 | 24-08-2017 14:17 |
| 32 | 313.3 | 24-08-2017 14:17 |
| 68 | 313.3 | 24-08-2017 14:19 |
| 68 | 313.3 | 24-08-2017 14:19 |
| 18 | 313.3 | 24-08-2017 14:19 |
| 29 | 313.3 | 24-08-2017 14:19 |
| 68 | 313.3 | 24-08-2017 14:19 |
| 51 | 313.3 | 24-08-2017 14:20 |
| 25 | 313.3 | 24-08-2017 14:20 |
| 53 | 313.3 | 24-08-2017 14:20 |
| 39 | 313.3 | 24-08-2017 14:20 |
Rethink Tomorrow
novozymes
Selskabsmeddelelse nr. 59
15/18
| 17 | 313.2 | 24-08-2017 14:26 |
|---|---|---|
| 6 | 313.2 | 24-08-2017 14:26 |
| 32 | 313.2 | 24-08-2017 14:26 |
| 24 | 313.2 | 24-08-2017 14:31 |
| 22 | 313.2 | 24-08-2017 14:33 |
| 2 | 313.2 | 24-08-2017 14:33 |
| 5 | 313.2 | 24-08-2017 14:33 |
| 52 | 313.2 | 24-08-2017 14:47 |
| 96 | 313.2 | 24-08-2017 14:47 |
| 96 | 313.2 | 24-08-2017 14:47 |
| 13 | 313.2 | 24-08-2017 14:47 |
| 21 | 313.2 | 24-08-2017 14:47 |
| 34 | 313.2 | 24-08-2017 14:47 |
| 14 | 313.2 | 24-08-2017 14:47 |
| 39 | 313.2 | 24-08-2017 14:47 |
| 52 | 313.2 | 24-08-2017 14:47 |
| 150 | 313.2 | 24-08-2017 14:47 |
| 76 | 313.2 | 24-08-2017 14:47 |
| 52 | 313.2 | 24-08-2017 14:47 |
| 160 | 313.2 | 24-08-2017 14:47 |
| 49 | 313.2 | 24-08-2017 14:47 |
| 370 | 313.2 | 24-08-2017 14:47 |
| 3 | 313.2 | 24-08-2017 14:47 |
| 9 | 313.1 | 24-08-2017 14:53 |
| 107 | 313.1 | 24-08-2017 14:56 |
| 52 | 313.1 | 24-08-2017 14:56 |
| 54 | 313.1 | 24-08-2017 14:56 |
| 122 | 313.1 | 24-08-2017 14:56 |
| 79 | 313.1 | 24-08-2017 14:56 |
| 27 | 313.2 | 24-08-2017 15:02 |
| 12 | 313.2 | 24-08-2017 15:02 |
| 21 | 313.2 | 24-08-2017 15:02 |
| 37 | 313.2 | 24-08-2017 15:02 |
| 2 | 313.2 | 24-08-2017 15:02 |
| 100 | 313.3 | 24-08-2017 15:04 |
| 27 | 313.3 | 24-08-2017 15:04 |
| 2 | 313.3 | 24-08-2017 15:04 |
| 20 | 313.3 | 24-08-2017 15:04 |
| 43 | 313.3 | 24-08-2017 15:05 |
| 25 | 313.3 | 24-08-2017 15:05 |
| 10 | 313.3 | 24-08-2017 15:05 |
| 50 | 313.3 | 24-08-2017 15:05 |
| 6 | 313.3 | 24-08-2017 15:05 |
| 52 | 313.3 | 24-08-2017 15:05 |
| 48 | 313.3 | 24-08-2017 15:05 |
| 11 | 313.3 | 24-08-2017 15:05 |
Rethink Tomorrow
novozymes
Selskabsmeddelelse nr. 59
16/18
| 32 | 313.3 | 24-08-2017 15:05 |
|---|---|---|
| 6 | 313.4 | 24-08-2017 15:09 |
| 60 | 313.4 | 24-08-2017 15:09 |
| 19 | 313.4 | 24-08-2017 15:09 |
| 49 | 313.4 | 24-08-2017 15:09 |
| 72 | 313.4 | 24-08-2017 15:09 |
| 7 | 313.4 | 24-08-2017 15:09 |
| 2 | 313.6 | 24-08-2017 15:10 |
| 33 | 313.6 | 24-08-2017 15:10 |
| 8 | 313.6 | 24-08-2017 15:10 |
| 63 | 313.6 | 24-08-2017 15:10 |
| 14 | 313.6 | 24-08-2017 15:10 |
| 19 | 313.6 | 24-08-2017 15:10 |
| 26 | 313.6 | 24-08-2017 15:10 |
| 43 | 313.6 | 24-08-2017 15:10 |
| 16 | 313.6 | 24-08-2017 15:10 |
| 22 | 313.6 | 24-08-2017 15:10 |
| 29 | 313.5 | 24-08-2017 15:17 |
| 111 | 313.5 | 24-08-2017 15:17 |
| 5 | 313.5 | 24-08-2017 15:17 |
| 105 | 313.5 | 24-08-2017 15:17 |
| 138 | 313.5 | 24-08-2017 15:20 |
| 29 | 313.5 | 24-08-2017 15:20 |
| 85 | 313.5 | 24-08-2017 15:20 |
| 162 | 313.6 | 24-08-2017 15:21 |
| 34 | 313.6 | 24-08-2017 15:22 |
| 58 | 313.6 | 24-08-2017 15:22 |
| 13 | 313.6 | 24-08-2017 15:22 |
| 73 | 313.6 | 24-08-2017 15:22 |
| 18 | 313.6 | 24-08-2017 15:22 |
| 40 | 313.6 | 24-08-2017 15:22 |
| 10 | 313.9 | 24-08-2017 15:23 |
| 90 | 313.9 | 24-08-2017 15:23 |
| 2 | 313.9 | 24-08-2017 15:23 |
| 18 | 313.9 | 24-08-2017 15:23 |
| 69 | 313.9 | 24-08-2017 15:23 |
| 15 | 313.9 | 24-08-2017 15:23 |
| 11 | 313.9 | 24-08-2017 15:23 |
| 26 | 313.9 | 24-08-2017 15:23 |
| 12 | 313.9 | 24-08-2017 15:24 |
| 31 | 313.9 | 24-08-2017 15:24 |
| 31 | 313.9 | 24-08-2017 15:24 |
| 51 | 313.6 | 24-08-2017 15:26 |
| 36 | 313.6 | 24-08-2017 15:26 |
| 71 | 313.6 | 24-08-2017 15:26 |
| 29 | 313.6 | 24-08-2017 15:26 |
Rethink Tomorrow
novozymes
Selskabsmeddelelse nr. 59
17/18
| 9 | 313.6 | 24-08-2017 15:26 |
|---|---|---|
| 34 | 313.7 | 24-08-2017 15:30 |
| 33 | 313.7 | 24-08-2017 15:30 |
| 18 | 313.7 | 24-08-2017 15:30 |
| 48 | 313.7 | 24-08-2017 15:30 |
| 29 | 313.7 | 24-08-2017 15:30 |
| 39 | 313.7 | 24-08-2017 15:32 |
| 12 | 313.7 | 24-08-2017 15:32 |
| 39 | 313.7 | 24-08-2017 15:32 |
| 80 | 313.7 | 24-08-2017 15:32 |
| 80 | 313.7 | 24-08-2017 15:32 |
| 73 | 313.7 | 24-08-2017 15:32 |
| 19 | 313.7 | 24-08-2017 15:32 |
| 24 | 313.7 | 24-08-2017 15:33 |
| 31 | 313.7 | 24-08-2017 15:33 |
| 16 | 313.7 | 24-08-2017 15:33 |
| 17 | 313.7 | 24-08-2017 15:33 |
| 36 | 313.7 | 24-08-2017 15:33 |
| 36 | 313.7 | 24-08-2017 15:34 |
| 7 | 313.7 | 24-08-2017 15:34 |
| 8 | 313.7 | 24-08-2017 15:34 |
| 1 | 313.7 | 24-08-2017 15:34 |
| 16 | 313.7 | 24-08-2017 15:34 |
| 76 | 313.7 | 24-08-2017 15:38 |
| 99 | 313.7 | 24-08-2017 15:38 |
| 59 | 313.7 | 24-08-2017 15:38 |
| 26 | 313.7 | 24-08-2017 15:38 |
| 30 | 313.6 | 24-08-2017 15:41 |
| 178 | 313.6 | 24-08-2017 15:41 |
| 50 | 313.6 | 24-08-2017 15:41 |
| 69 | 313.7 | 24-08-2017 15:42 |
| 19 | 313.7 | 24-08-2017 15:42 |
| 64 | 313.7 | 24-08-2017 15:42 |
| 5 | 313.7 | 24-08-2017 15:42 |
| 1 | 313.7 | 24-08-2017 15:42 |
| 116 | 313.7 | 24-08-2017 15:42 |
| 33 | 313.7 | 24-08-2017 15:42 |
| 51 | 313.7 | 24-08-2017 15:42 |
| 71 | 313.7 | 24-08-2017 15:42 |
| 48 | 313.8 | 24-08-2017 15:42 |
| 1 | 313.8 | 24-08-2017 15:42 |
| 2 | 313.8 | 24-08-2017 15:42 |
| 20 | 313.8 | 24-08-2017 15:42 |
| 32 | 313.8 | 24-08-2017 15:42 |
| 44 | 313.9 | 24-08-2017 15:44 |
| 29 | 313.9 | 24-08-2017 15:44 |
Rethink Tomorrow
novozymes
Selskabsmeddelelse nr. 59
18/18
| 12 | 313.9 | 24-08-2017 15:44 |
|---|---|---|
| 19 | 313.9 | 24-08-2017 15:44 |
| 90 | 313.8 | 24-08-2017 15:46 |
| 69 | 313.8 | 24-08-2017 15:46 |
| 26 | 313.8 | 24-08-2017 15:46 |
| 33 | 313.8 | 24-08-2017 15:46 |
| 11 | 313.8 | 24-08-2017 15:46 |
| 18 | 314 | 24-08-2017 15:47 |
| 24 | 314 | 24-08-2017 15:47 |
| 52 | 314 | 24-08-2017 15:47 |
| 10 | 314 | 24-08-2017 15:47 |
| 26 | 314 | 24-08-2017 15:47 |
| 40 | 314 | 24-08-2017 15:47 |
| 35 | 314 | 24-08-2017 15:48 |
| 12 | 314 | 24-08-2017 15:48 |
| 52 | 314 | 24-08-2017 15:48 |
| 19 | 314 | 24-08-2017 15:48 |
| 100 | 313.7 | 24-08-2017 15:53 |
| 89 | 313.7 | 24-08-2017 15:53 |
| 68 | 313.7 | 24-08-2017 15:53 |
| 16 | 313.7 | 24-08-2017 15:55 |
| 50 | 313.7 | 24-08-2017 15:55 |
| 41 | 313.7 | 24-08-2017 15:55 |
| 81 | 313.7 | 24-08-2017 15:55 |
| 25 | 313.7 | 24-08-2017 15:55 |
| 21 | 313.7 | 24-08-2017 15:55 |
| 81 | 313.7 | 24-08-2017 15:55 |
| 66 | 313.7 | 24-08-2017 15:56 |
| 9 | 313.7 | 24-08-2017 15:56 |
| 18 | 313.7 | 24-08-2017 15:56 |
| 4 | 313.7 | 24-08-2017 15:56 |
| 19 | 313.7 | 24-08-2017 15:56 |
| 36 | 313.7 | 24-08-2017 15:57 |
| 42 | 313.7 | 24-08-2017 15:57 |
| 1 | 313.7 | 24-08-2017 15:57 |
| 27 | 313.7 | 24-08-2017 15:57 |
| 12 | 313.7 | 24-08-2017 15:57 |
| 19 | 313.6 | 24-08-2017 15:59 |
| 49 | 313.6 | 24-08-2017 15:59 |
| 31 | 313.6 | 24-08-2017 15:59 |
| 56 | 313.6 | 24-08-2017 15:59 |
| 83 | 313.5 | 24-08-2017 15:59 |
| 69 | 313.5 | 24-08-2017 15:59 |
Rethink Tomorrow
novozymes